
Results
26
Mid-Large Cap Stocks
26 companies
PharmaResearch
Market Cap: ₩3.0t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩289,000.00
7D
0.9%
1Y
-33.3%
Yuhan
Market Cap: ₩5.8t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩77,200.00
7D
-0.4%
1Y
-27.5%
Samsung BiologicsLtd
Market Cap: ₩59.9t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,295,000.00
7D
-3.4%
1Y
-17.3%
Samsung Epis Holdings
Market Cap: ₩11.1t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩446,500.00
7D
0.6%
1Y
n/a
L&C BIOLTD
Market Cap: ₩2.1t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩76,900.00
7D
-10.8%
1Y
153.0%
SK bioscienceLtd
Market Cap: ₩3.1t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩39,200.00
7D
-1.9%
1Y
-12.6%
Hanall Biopharma
Market Cap: ₩2.6t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩51,500.00
7D
-11.1%
1Y
96.2%
D&D Pharmatech
Market Cap: ₩3.8t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩87,500.00
7D
-5.2%
1Y
258.2%
NatureCellLtd
Market Cap: ₩2.1t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩32,000.00
7D
-5.7%
1Y
10.9%
Hanmi Pharm
Market Cap: ₩5.2t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩411,000.00
7D
-16.8%
1Y
37.5%
Peptron
Market Cap: ₩5.4t
Engages in the development of peptide-based medicines.
A087010
₩230,000.00
7D
-9.3%
1Y
23.5%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩244,500.00
7D
-0.6%
1Y
-31.3%
ALTEOGEN
Market Cap: ₩18.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩337,000.00
7D
1.4%
1Y
-12.6%
Celltrion Pharm
Market Cap: ₩1.9t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩42,900.00
7D
-1.9%
1Y
-12.5%
ABL Bio
Market Cap: ₩5.1t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩91,100.00
7D
-8.7%
1Y
22.6%
Mezzion PharmaLtd
Market Cap: ₩2.0t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩64,700.00
7D
4.0%
1Y
59.6%
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,900.00
7D
-0.2%
1Y
-2.7%
ST PharmLtd
Market Cap: ₩2.5t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩122,000.00
7D
2.1%
1Y
50.2%
Aimed Bio
Market Cap: ₩1.8t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩27,200.00
7D
2.6%
1Y
n/a
Caregen
Market Cap: ₩3.7t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩74,800.00
7D
-3.9%
1Y
126.7%
Celltrion
Market Cap: ₩38.0t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩173,000.00
7D
0.9%
1Y
13.0%
Kolon TissueGene
Market Cap: ₩8.7t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩102,600.00
7D
3.4%
1Y
178.4%
Sam Chun Dang Pharm
Market Cap: ₩6.1t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩261,500.00
7D
-10.4%
1Y
62.0%
OliX Pharmaceuticals
Market Cap: ₩2.3t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩115,200.00
7D
-22.6%
1Y
164.5%
LigaChem Biosciences
Market Cap: ₩4.8t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩129,200.00
7D
-5.1%
1Y
18.6%
Voronoi
Market Cap: ₩3.5t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩193,500.00
7D
-7.6%
1Y
102.0%